Recorded January 12, 2023
As much of the world has seemingly moved on from COVID-19 despite the ongoing global health emergency, the virus continues to pose serious risks for those who are immunocompromised. However, as the virus and the options for protection and treatment are changing, we must remain hopeful for the future. Immunologist Dr. Shahzad Mustafa, will speak about the immune vulnerabilities of CLL / SLL patients despite their treatment status, and prevention methods to protect against the SARS-CoV-2 virus. Hematologist Dr. Andres Chang will provide an update on the latest COVID-19 variants and available treatments. Both presentations will be brief, as the majority of the event will be dedicated to answering audience questions about COVID-19 and CLL / SLL.
Speakers:
Moderator:
Brian Koffman, MDCM (retired), MS Ed
Co-Founder, Executive Vice President, and Chief Medical Officer
CLL Society
Speaker:
S. Shahzad Mustafa, MD
Lead Physician – Allergy, Immunology, & Rheumatology, Rochester Regional Health, Clinical Associate Professor of Medicine, University of Rochester School of Medicine and Dentistry
Speaker:
Andres Chang, MD, PhD
Instructor, Department of Hematology and Medical Oncology at Winship Cancer Institute of Emory University
Speaker:
Robyn Brumble, MSN, RN
Director of Scientific Affairs & Research, CLL Society
CLL Society Resources
- Download Slides
- COVID-19 Action Plan: Checklists to Prepare for Pre and Post COVID-19 Exposure
- COVID-19 Weekly Updates
- CLL Society’s Official COVID-19 Triage Statement
- CLL Society’s Official Statement on Evusheld, Boosters, and COVID-19 Therapies
- The Most Recent COVID-19 Vaccination Schedule for CLL / SLL Patients
- Sign up for CLL Society Weekly Emails
- CLL Society Support Groups
This program was made possible through grant support from AstraZeneca and BeiGene.
